Cefotaxime for Injection (Hospira, Inc.)

Hazard statements (CLP)

H317, H334

Code

Statements

H317

May cause an allergic skin reaction

SECTION 2: Hazards identification

OSHA Classification of the Substance or Mixture GHS - Classification Respiratory Sensitization: Category 1 Skin Sensitization: Category 1

Signal word

Danger

Hazard statements

H334 - May cause allergy or asthma symptoms or breathing difficulties if inhaled H317 - May cause an allergic skin reaction May form combustible dust concentrations in air

Precautionary statements

P272 - Contaminated work clothing must not be allowed out of the workplace P261 - Avoid breathing dust/fume/gas/mist/vapors/spray P280 - Wear protective gloves/protective clothing/eye protection/face protection P285 - In case of inadequate ventilation wear respiratory protection P304 + P341 - IF INHALED: If breathing is difficult, remove to fresh air and keep at rest in a position comfortable for breathing P342 + P311 - If experiencing respiratory symptoms: Call a POISON CENTRE or doctor/physician P302+ P352 - IF ON SKIN: Wash with plenty of soap and water P333 + P313 - If skin irritation or rash occurs: Get medical advice/attention P321 - Specific treatment (see supplemental first aid instructions on this label) P363 - Wash contaminated clothing before reuse P501 - Dispose of contents/container in accordance with all local and national regulations

Other hazards

Note No data available This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the active substance or its intermediates regardless of the potential risk. The precautionary statements and warnings included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.

2.1 Classification of the substance or mixture

GHS - Classification Respiratory Sensitization: Category 1 Skin Sensitization: Category 1 US OSHA Specific - Classification Physical Hazard: Combustible Dust